Ab Index-Nr. 607-414-00-6

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
607-414-00-6tris(2-ethylhexyl)-4,4',4''-(1,3,5-
triazine-2,4,6-triyltriimi­no)tri­benzoate
402-070-188122-99-0Aquatic Chronic 4H413H413   
607-415-00-1poly-(methyl methacrylate)-co-
(butyl­methacrylate)-co-(4-acryloxy­butyl-isopropenyl-α, α-dimethylbenzyl carbamate)-co-(maleican­hydride)
419-590-1Flam. Sol. 1
Skin Sens. 1
H228
H317
GHS02
GHS07
Dgr
H228
H317
  T
607-416-00-74-(2-carboxymethylthio)etho-
xy-1-hydroxy-5-isobutyloxy­carbonylamino-N-(3-dodecy­loxypropyl)-2-naphthamide
420-730-7Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-417-00-23-chloropropyl chloroformiate425-770-9628-11-5Acute Tox. 3 *
Acute Tox. 4 *
STOT RE 2 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H331
H302
H373 **
H315
H318
H317
GHS06
GHS05
GHS08
Dgr
H331
H302
H373 **
H315
H318
H317
   
607-418-00-82-ethylhexyl 4-aminobenzoate420-170-326218-04-2Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-419-00-3(3'-carboxymethyl-5-(2-(3-
ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid
422-240-9166596-68-5Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
607-420-00-92,2-bis(hydroxymethyl)bu-
tanoic acid
424-090-110097-02-6Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
607-421-00-4cypermethrin cis/trans +/- 40/60;
(RS)-α-cyano-3-phenoxy­benzyl (1RS,3RS;1RS,3SR)-3-(2,2-di­chlorovinyl)-2,2-dimethylcyclo­propanecarboxylate
257-842-952315-07-8Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H335
H400
H410
GHS07
GHS09
Wng
H332
H302
H335
H410
   
607-422-00-Xα-cypermethrin (ISO);
racemate comprising (R)-α-cyano-3-phe-
noxy­ben­zyl(1S,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;
(S)-α-cyano-3-phenoxy-
benzyl(1R,3R)-3-(2,2-dichlorovinyl)-2,2-di­methyl­cyclo­propane­car­boxy­late
257-842-967375-30-8Acute Tox. 3 *
STOT RE 2 *
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H301
H373 **
H335
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H373 **
H335
H410
 M = 1000 
607-423-00-5esters of mecoprop and of mecoprop-PAcute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
  A
607-424-00-0trifloxystrobin (ISO);
(E,E)-α-methoxyimino-{2-
[[[[1-[3-(trifluoromethyl)phe-
nyl]ethylidene]amino]oxy]me-
thyl]benzene­acetic acid methyl ester
141517-21-7Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
607-425-00-6metalaxyl (ISO);
methyl-N-(2,6-dimethylphenyl)-
N-(methoxyacetyl)-DL-alaninate
260-979-757837-19-1Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 3
H302
H317
H412
GHS07
Wng
H302
H317
H412
   
607-426-00-11,2-benzenedicarboxylic acid, dipentylester,
branched and linear; [1]
n-pentyl-isopentylphthalate; [2]
di-n-pentyl phthalate; [3]
diisopentylphthalate [4]
284-032-2 [1]
[2]
205-017-9 [3]
210-088-4 [4]
84777-06-0 [1]
[2]
131-18-0 [3]
605-50-5 [4]
Repr. 1B
Aquatic Acute 1
H360FD
H400
GHS08
GHS09
Dgr
H360FD
H400
   
607-427-00-7bromoxynil heptanoate (ISO);
2,6-dibromo-4-cyanophenyl heptanoate
260-300-456634-95-8Repr. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361d
(*)(*)(*)
H332
H302
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361d
(*)(*)(*)
H332
H302
H317
H410
   
607-428-00-2tetrasodium ethylene diamine tetraacetate200-573-964-02-8Acute Tox. 4 *
Eye Dam. 1
H302
H318
GHS05
GHS07
Dgr
H302
H318
   
607-429-00-8edetic acid;
(EDTA)
200-449-460-00-4Eye Irrit. 2H319GHS07
Wng
H319   
607-430-00-3BBP;
benzyl butyl phthalate e
201-622-785-68-7Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H360Df
H400
H410
GHS08
GHS09
Dgr
H360Df
H410
   
607-431-00-9prallethrin (ISO);
ETOC;
2-methyl-4-oxo-3-(prop-2-
ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-
1-enyl)cyclopropanecarboxylate
245-387-923031-36-9Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H331
H302
H400
H410
GHS06
GHS09
Dgr
H331
H302
H410
   
607-432-00-4S-metolachlor;
reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1]
(R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2]
[1]
[2]
87392-12-9 [1]
178961-20-1
[2]
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
607-433-00-Xcypermethrin cis/trans +/- 80/20;
(RS)-α-cyano-3-pheno-
xybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-
dimethyl­cyclopro-
pane­carboxylate
257-842-952315-07-8Acute Tox. 4 (*)
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H335
H315
H317
H400
H410
GHS07
GHS09
Wng
H302
H335
H315
H317
H410
   
607-434-00-5mecoprop-P [1] and its salts;
(R)-2-(4-chloro-2-methyl­phenoxy)propionic acid
240-539-016484-77-8Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
   
607-435-00-02S-isopropyl-5R-methyl-1R-
cyclohexyl 2,2-dihydroxyacetate
416-810-6111969-64-3STOT RE 2 (*)
Eye Dam. 1
Aquatic Chronic 2
H373 (*)(*)
H318
H411
GHS08
GHS05
GHS09
Dgr
H373 (*)(*)
H318
H411
   
607-436-00-62-hydroxy-3-(2-ethyl-4-methyl-
imidazoyl) propyl neodecanoate
417-350-9Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H315
H318
H400
H410
GHS05
GHS09
Dgr
H315
H318
H410
   
607-437-00-13-(4-aminophenyl)-2-cyano-2-
propenoic acid
417-480-6252977-62-1Skin Sens. 1H317GHS07
Wng
H317   
607-438-00-7methyl-2-[(aminosulfonyl)me-
thyl]benzoate
419-010-5112941-26-1Acute Tox. 4 (*)
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
   
607-439-00-2methyl tetrahydro-2-furan-
carboxylate
420-670-137443-42-8Eye Dam. 1H318GHS05
Dgr
H318   
607-440-00-8methyl 2-aminosulfonyl-6-
(trifluoro­methyl)pyridine-
3-carboxylate
421-220-7144740-59-0Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
607-441-00-33-[3-(2-dodecyloxy-5-methyl-
phenylcarbamoyl)-4-hydroxy-1-
naphthylthio]propionic acid
421-490-6167684-63-1Aquatic Chronic 4H413H413   
607-442-00-9benzyl [hydroxy-(4-
phenyl­butyl)phos-
phinyl] acetate
416-050-587460-09-1Eye Dam. 1H318GHS05
Dgr
H318   
607-444-00-Xreaction mass of:
cis-1,4-di­methyl-
cyclohexyl dibenzoate;
trans-1,4-dimethylcyclohexyl dibenzoate
416-230-335541-81-2Aquatic Chronic 4H413H413   
607-445-00-5Iron (III) tris(4-methyl-
benzene­sulfonate)
420-960-877214-82-5Eye Dam. 1H318GHS05
Dgr
H318   
607-446-00-0methyl 2-[4-(2-chloro-4-
nitro­phenylazo)-3-(1-
oxopropyl)ami­no]phe-
nyl­aminopropionate
416-240-8155522-12-6Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
607-447-00-6sodium 4-[4-(4-hydroxy-
phenylazo)phenylamino]-3-
nitroben­zenesulfonate
416-370-5156738-27-1Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
607-448-00-12,3,5,6-tetrafluorobenzoic acid416-800-1652-18-6Skin Irrit. 2
Eye Dam. 1
H315
H318
GHS05
Dgr
H315
H318
   
607-449-00-7reaction mass of:
4,4',4''-[(2,4,6-trio­xo-
1,3,5(2H,4H,6H)-tria­zine-
1,3,5-triyl)tris[methyle-
ne(3,5,5-trimethyl-3,1-cyclo-
hexa­nediyl)imino-
carbonyloxy-2,1-ethane-
diyl(ethyl)amino]]trisben-
zenediazo­niumtri[bis(2-
methyl­propyl)naphthale-
ne­sulfonate];
4,4',4'',4'''-[[5,5'-[carbonylbis[imi-
no(1,5,5-trimethyl-3,1-cyclo-
hexanediyl)methy­lene]]-
2,4,6-trioxo-1,3,5(2H,4H,6H)-
tria­zine-1,1',3,3'-tetrayl]te-
tra­kis[methyle-
ne(3,5,5-tri­methyl-3,1-
cyclo­hexanediyl)imino-
carbo­nyloxy-2,1-ethane-
diyl(ethyl)ami­no]]tetra-
kis­benzene­diazo-
nium­tetra[bis(2-methyl-
propyl)naphtha­lene-
sulfonate]
417-080-1Self-react. D
(*)(*)(*)(*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H242
H317
H400
H410
GHS02
GHS07
GHS09
Dgr
H242
H317
H410
   
607-450-00-22-mercaptobenzothiazolyl-(Z)-
(2-aminothiazol-4-yl)-2-(tert-
butoxycarbonyl) isopro-
poxyimino­acetate
419-040-989604-92-2Aquatic Chronic 4H413H413   
607-451-00-84-[4-amino-5-hydroxy-3-(4-(2-
sulfoxyethyl­sulfonyl)phe-
ny­lazo)-2,7-disulfo-
napht-6-ylazo]-6-[3-(4-amino-
5-hydroxy-3-(4-(2-sulfoxyethyl-
sulfonyl)pheny­lazo)-2,7-
disulfo­napht-6-ylazo]phe-
nyl­carbonyl­ami-
no]benze­nesul­fonic acid, sodium salt
417-640-5161935-19-9Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
607-453-00-94-benzyl-2,6-dihydroxy-4-aza-
heptylene bis(2,2-di-
methyl­octanoate)
418-100-1172964-15-7Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
607-454-00-4reaction mass of:
trans-2-(1-methylethyl)-1,3-
dioxane-5-carboxylic acid;
cis-2-(1-methylethyl)-1,3-
dioxane-5-carboxylic acid
418-170-3116193-72-7Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
607-455-00-X1-amino-4-(3-[4-chloro-6-(2,5-
di-sulfophe­nylamino)-
1,3,5-triazin-2-ylamino]-2,2-
di­methyl-propylamino)-
anthraqui­none-2-
sulfonic acid, sodium/lithium salt
419-520-8172890-93-6Skin Sens. 1H317GHS07
Wng
H317   
607-456-00-53-amino-4-chlorobenzoic acid, hexadecyl ester419-700-6143269-74-3Aquatic Chronic 2H411GHS09H411   
607-457-00-0tetrasodium dihydrogen 1,1''-di-
hydroxy-8,8''-[p-phenylbis(imi-
no-{6-[4-(2-amino­ethyl)pi-
perazin-1-yl]}-1,3,5-triazine-
4,2-di­ylimino)]bis(2,2'-
azo­naphthalene-1',3,6-
trisulfonate)
420-350-1172277-97-3Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
   
607-458-00-6reaction mass of: 2-ethyl-[2,6-
dibromo-4-[1-[3,5-dibromo-4-(2-
hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate;
2,2'-diethyl-[4,4'-bis(2,6-dibromo-
phenoxy)-1-methylethylidene] dipropenoate;
2,2'-[(1-methylethylidene)bis[[2,6-
dibromo-4,1-phenylene)oxy]ethanol]]
420-850-1Aquatic Chronic 2H411GHS09H411   
607-459-00-1isopentyl 4-{2-[5-cyano-1,2,3,6-
tetrahy­dro-1-(2-isopro-
poxyethoxy-carbonylmethyl)-
4-methyl-2,6-dioxo-3-pyridyli-
dene]hydrazino}ben­zoate
418-930-4Aquatic Chronic 4H413H413   
607-460-00-73-tridecyloxy-propyl-ammonium 9-octadecenoate418-990-1778577-53-0STOT RE 2 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H373 (*)(*)
H319
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H373 (*)(*)
H319
H315
H410
   
607-461-00-2reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-
(2-sulfo­nato-phenylazo)-
naphthalen-1-ylazo]-phenylami-
no}-6-[3-(2-sulfato-ethanesulfo-
nyl)-phenylamino]-1,3,5-triazin-
2-ylamino}-benzene-1,4-
disulfonate;
pentasodium 2-{4-{3-methyl-
4-[7-sulfonato-4-(2-sulfonato-
phenylazo)-naphthalen-1-ylazo]-
phenylamino}-6-[3-(2-sulfato-
ethanesulfonyl)-phenylamino]-
1,3,5-triazin-2-ylamino}-
benzene-1,4-di­sulfonate
421-160-1Aquatic Chronic 3H412H412   
607-462-00-8reaction mass of: 1-hexyl acetate;
2-methyl-1-pentyl acetate;
3-methyl-1-pentyl acetate;
4-methyl-1-pentyl acetate;
other mixed linear and branched C6-alkyl acetates
421-230-188230-35-7Aquatic Chronic 2H411GHS09H411   
607-463-00-33-(phenothiazin-10-yl)propionic acid421-260-5362-03-8Aquatic Chronic 2H411GHS09H411   
607-464-00-9reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-
dihydro-4-oxo-quinoline-3-
carboxylic acid;
5-chloro-1-ethyl-6-fluoro-1,4-
dihydro-4-oxo-quinoline-3-
carboxylic acid
421-280-4 Aquatic Chronic 3H412H412   
607-465-00-4tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-
hydroxy-6-oxidopyrimidin-5-
ylazo)benzamido]-2-ethoxy-
phenylazo}naphthalene-1,3-
disulfonate
421-440-3778583-04-3Aquatic Chronic 3H412H412   
607-466-00-Xreaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecylo-
xycarbonyl)phenylcarbamoyl]-
3,3-dimethyl-2-oxobutyl)-1H-
2,3,3a,7a-tetrahydrobenzotri-
azole-5-carboxylate;
phenyl 2-(1-(2-chloro-5-
(hexadecyloxycarbonyl)phe-
nylcarbamoyl)-3,3-dimethyl-2-
oxobutyl)-1H-2,3,3a,7a-tetrahy-
drobenzotriazole-5-carboxylate;
phenyl 3-(1-(2-chloro-5-
(hexadecyloxycarbonyl)phe-
nylcarbamoyl)-3,3-dimethyl-2-
oxobutyl)-1H-2,3,3a,7a-tetrahy-
drobenzotriazole-5-carboxylate
421-480-1Aquatic Chronic 2H411GHS09H411   
607-467-00-51,1,3,3-tetrabutyl-1,3-ditinoxy-
dicaprylate
419-430-956533-00-7Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H373 (*)(*)
H314
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H312
H302
H373 (*)(*)
H314
H410
   
607-468-00-0reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxy-
phenylamino)-6-chloro-1,3,5-
triazine-2-yl)amino)-2-((1,4-di-
methyl-6-oxido-2-oxo-5-sulfona-
tomethyl-1,2-dihydropyridine-3-
yl)azo)benzenesulfo-nate;
disodium 4-((4-(5-sulfonato-2-methoxy-
phe-nylamino)-6-chloro-1,3,5-
triazine-2-yl)amino)-2-((1,4-di-
methyl-6-oxido-2-oxo-5-sulfona-
tomethyl-1,2-dihydropyridine-3-
yl)azo)benzenesulfonate;
trisodium 4-((4-(5-sulfonato-2-methoxy-
phenylamino)-6-chloro-1,3,5-
triazine-2-yl)amino)-2-((1,4-di-
methyl-6-oxido-2-oxo-5-sulfona-
tomethyl-1,2-dihydropyridine-3-
yl)azo)benzenesulfonate;
tetrasodium 4-((4-(5-sulfonato-2-methoxy-
phenylamino)-6-chloro-1,3,5-
triazine-2-yl)amino)-2-((1,4-di-
methyl-6-oxido-2-oxo-5-sulfona-
tomethyl-1,2-dihydropyridine-3-
yl)azo)benzenesulfonate
419-450-8Skin Sens. 1H317GHS07
Wng
H317   
607-469-00-6disodium 7-((4,6-bis(3-
diethylaminopropylamino)-1,3,5-
triazine-2-yl)amino)-4-hyd-roxy-
3-(4-(4-sulfonatophenylazo)phe-
nylazo)-2-naphthalene sulfonate
419-460-2120029-06-3Aquatic Chronic 3H412H412   
607-470-00-1potassium sodium 6,13-
dichloro-3,10-bis{2-[4-[3-(2-
hydroxysulphonyloxyethane-
sulfonyl)phenylamino]-6-(2,5-
disulfonatophenylamino)-1,3,5-
triazin-2-ylamino]ethylami-
no}benzo[5,6][1,4]oxazino[2,3-
b]phenoxazine-4,11-disulfonate
414-100-0154336-20-6Eye Dam. 1
Aquatic Chronic 3
H318
H412
GHS05
Dgr
H318
H412
   
607-471-00-71,6-bis((dibenzylthiocarbamoyl)
disulfanyl)hexane
429-280-6151900-44-6Aquatic Chronic 4H413H413   
607-473-00-8pentaerythritol, dipentaerythritol,
fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid
426-590-3187412-41-5Skin Sens. 1H317GHS07
Wng
H317   
607-474-00-3(4-(4-(4-dimethylaminoben-
zyliden-1-yl)-3-methyl-5-oxo-2-
pyrazolin-1-yl)benzoic acid
410-430-4117573-89-4Aquatic Chronic 4H413H413   
607-475-00-9reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-
sulfonatophenyl)amino]-1,3,5-
triazin-2-ylamino]-2-ureidophe-
nylazo)naphthalene-1,3,6-tri-
sulfonate;
tetrasodium 7-(4-[4-chloro-6-[methyl-(4-
sulfonatophenyl)amino]-1,3,5-
triazin-2-ylamino]-2-ureidophe-
nylazo)naphthalene-1,3,6-tri-
sulfonate (1:1)
412-940-2148878-18-6Skin Sens. 1H317GHS07
Wng
H317   
607-476-00-4trisodium N,N-bis(carboxymethyl)-β-alanine414-070-9129050-62-0Skin Corr. 1B
Aquatic Chronic 3
H314
H412
GHS05
Dgr
H314
H412
   
607-477-00-X(1α5α6α)-6-
nitro-3-benzyl-3-azabicyc-
lo[3.1.0]hexane methanesulfonate salt
426-740-8Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
   
607-478-00-5tetramethylammonium hydrogen phthalate416-900-579723-02-7Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1
H301
H373 (*)(*)
H400
GHS06
GHS08
GHS09
Dgr
H301
H373 (*)(*)
H400
   
607-479-00-0hexadecyl 4-chloro-3-
[2-(5,5-dimethyl-2,4-dioxo-1,3-
oxazolidin-3-yl)-4,4-dimethyl-3-
oxopentamido]benzoate
418-550-9168689-49-4Aquatic Chronic 4H413H413   
607-480-00-61,2-benzenedicarboxylic acid;
di-C7-11-branched and linear alkylesters
271-084-668515-42-4Repr. 1BH360DfGHS08
Dgr
H360Df   
607-481-00-1reaction mass of: trihexyl citrate;
dihexyloctyl citrate;
dioctylhexyl citrate;
dihexyldecyl citrate
430-290-8Aquatic Chronic 4H413H413   
607-482-00-7N-[1-(S)-ethoxycarbonyl-3-
phenylpropyl]-l-alanyl-N-
carboxyanhydride
430-360-884793-24-8Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
607-483-00-21,2-benzenedicarboxylic acid;
di-C6-8-branched alkylesters, C7-rich
276-158-171888-89-6Repr. 1BH360D***GHS08
Dgr
H360D***   
607-484-00-8ethyl 2-{[3-acetylamino-
4-(6-bromo-2-methyl-1,3-dioxo-
2,3-dihydro-1H-isoindol-5-
ylazo)phenyl]ethylamino}pro-
pionate
430-480-0221452-67-1Aquatic Chronic 4H413H413   
607-485-00-3(3S-trans)-phenyl-3-[(1,3-ben-
zodioxol-5-yloxy)methyl]-4-(4-
fluorophenyl)-1-piperidinecar-
boxylate
430-510-2Aquatic Chronic 4H413H413   
607-486-00-9potassium sodium 5´-(6-chloro-
4-(2-(2-vinylsulfonylethoxy)ethyl-
amino)-1,3,5-triazin-2-ylamino)-
4´-hydroxy-2,3´-azodinaphthalene-
1,2´,5,7´-disulfonate
402-110-8110081-40-8Aquatic Chronic 3H412H412   
607-487-00-4reaction mass of: disodium 4-(3-ethoxycar-bonyl-4-(5-(3-
ethoxycarbonyl-5-hydroxy-1-(4-
sulfonatophenyl)pyrazol-4-
yl)penta-2,4-dienylidene)-4,5-
dihydro-5-oxopyrazol-1-yl)ben-
zenesulfonate;
trisodium 4-(3-ethoxycarbonyl-4-(5-(3-
ethoxycarbonyl-5-oxido-1-(4-
sulfonatophenyl)pyrazol-4-
yl)penta-2,4-dienylidene)-4,5-
dihydro-5-oxopyrazol-1-yl)ben-
zenesulfonate
402-660-9Repr. 1B
Aquatic Chronic 3
H360D
(*)(*)(*)
H412
GHS08
Dgr
H360D
(*)(*)(*)
H412
   
607-488-00-Xethyl (2-acetylamino-5-fluoro-
4-isothiocyanatophenoxy)acetate
414-210-9147379-38-2Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-489-00-5reaction mass of: 2-ethylhexyl linolenate,
linoleate and oleate;
2-ethylhexyl epoxyoleate;
2-ethylhexyl diepoxylinoleate;
2-ethylhexyl triepoxylinolenate
414-890-771302-79-9Skin Sens. 1H317GHS07
Wng
H317   
607-490-00-0N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate415-060-7Eye Dam. 1
Skin Sens. 1
H318
H317
GHS05
GHS07
Dgr
H318
H317
   
607-491-00-6reaction mass of: diester of
4,4´-methylenebis[2-(2-hydroxy-
5-methylbenzyl)-3,6-dimethyl-
phenol] and 6-diazo-5,6-
dihydro-5-oxonaphthalene-1-
sulfonic acid (1:2);
triester of 4,4´-methylene-
bis[2-(2-hydroxy-5-methylben-
zyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-
naphthalene-1-sulfonic acid (1:3)
427-140-9Carc. 2H351GHS08
Wng
H351   
607-492-00-12-(1-(3',3'-dimethyl-1'-cyclo-
hexyl)ethoxy)-2-methyl propyl propanoate
415-490-5141773-73-1Aquatic Chronic 2H411GHS09H411   
607-493-00-7methyl (3aR,4R,7aR)-2-methyl-
4-(1S,2R,3-triacetoxypropyl)-
3a,7a-dihydro-4H-pyrano[3,4-
d]oxazole-6-carboxylate
415-670-378850-37-0Eye Dam. 1H318GHS05
Dgr
H318   
607-494-00-2bis(2-ethylhexyl)octylphos-
phonate
417-170-052894-02-7Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-495-00-8sodium 4-sulfophenyl-6-
((1-oxo­nonyl)amino)he-
xanoate
417-550-6168151-92-6Skin Sens. 1H317GHS07
Wng
H317   
607-496-00-32,2'-methylenebis(4,6-di-tert-
butyl-phenyl)-2-ethylhexyl phosphite
418-310-3126050-54-2Aquatic Chronic 4H413H413   
607-497-00-9cerium oxide isostearate419-760-3Aquatic Chronic 4H413H413   
607-498-00-4(E)-3,7-dimethyl-2,6-octadi-
enylhexadecanoate
421-370-33681-73-0Skin Irrit. 2
Aquatic Chronic 4
H315
H413
GHS07
Wng
H315
H413
   
607-499-00-Xbis(dimethyl-(2-hydroxy-
ethyl)ammonium)
1,2-ethanediyl-bis(2-hexade-
cenylsuccinate)
421-660-1Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H318
H317
H411
   
607-500-00-3calcium 2,2,bis[(5-
tetrapropylene-2-hyd-
roxy)phenyl]ethanoate
421-670-4Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
   
607-501-00-9reaction mass of: triphenylthio-
phosphate and tertiary butylated phenyl derivatives
421-820-9192268-65-8Aquatic Chronic 4H413H413   
607-502-00-4(N-benzyl-N,N,N-tributyl)am-
monium 4-dodecylben-
zenesulfonate
422-200-0178277-55-9Skin Corr. 1B
Acute Tox. 4 (*)
Aquatic Chronic 2
H314
H302
H411
GHS05
GHS07
GHS09
Dgr
H314
H302
H411
   
607-503-00-X2,4,6-tri-n-propyl-2,4,6-trioxo-
1,3,5,2,4,6-trioxatriphosphori-
nane
422-210-568957-94-8Skin Corr. 1BH314GHS05
Dgr
H314   
607-504-00-5diammonium 1-hydroxy-2-
(4-(4-carboxyphenylazo)-2,5-
dimethoxyphenylazo)-7-amino-
3-naphthalenesulfonate
422-670-7Repr. 2
Acute Tox. 3 *
STOT RE 2 *
Aquatic Acute 1
Aquatic Chronic 1
H361f
H301
H373 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H361f
H301
H373 **
H410
   
607-505-00-0pentasodium 7-(4-(4-(5-
amino-4-sulfonato-2-(4-((2-
(sulfonato-ethoxy)sulfonyl)phe-
nylazo)phenylamino)-6-chloro-
1,3,5-triazin-2-yl)amino-2-ur-
eidophenylazo)naphtalene-
1,3,6-trisulfonate
422-930-1 Aquatic Chronic 3H412H412   
607-506-00-6reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-me-
thyl-5-oxo-1-(3-sulfonatophenyl)-
1H-pyrazol-4-yl)azo)-5-me-
thyl)benzenesulfonate;
disodium (4-chloro-2-((4,5-
dihydro-3-methyl-5-oxo-1-(3-
sulfonatophenyl)-1H-pyrazol-4-
yl)azo)-5-methyl)benzene-
sulfonate
422-970-8 Aquatic Chronic 2H411GHS09H411   
607-507-00-1potassium, sodium 2,4-di-
amino-3-[4-(2-sulfonatoetho-
xysulfonyl)phenylazo]-5-[4-(2-
sulfonatoethoxysulfonyl)-2-
sulfonatophenylazo]-benzene-
sulfonate
422-980-2187026-95-5Eye Dam. 1H318GHS05
Dgr
H318   
607-508-00-7disodium 3,3'-[iminobis[sul-
fonyl-4,1-phenylene-(5-hydroxy-
3-methylpyrazole-1,4-diyl)azo-
4,1-phenylenesulfonylimino-(4-
amino-6-hydroxypyrimidine-2,5-
diyl)azo-4,1-phenylenesulfo-
nylimino(4-amino-6-hydroxy-
pyrimidine-2,5-diyl)azo]bis(ben-
zenesulfonate)]
423-110-4Eye Dam. 1H318GHS05
Dgr
H318   
607-509-00-22-phenoxyethyl 4-aminobenzoate430-880-588938-23-2Aquatic Chronic 2H411GHS09H411   
607-510-00-8(2S,5R)-6,6-dibromo-3,3-
dimethyl-7-oxo-4-thia-1-azabi-
cyclo[3.2.0]heptane-2-car-
boxylic acid 4,4-dioxide
427-200-476646-91-8Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H302
H315
H318
H317
GHS05
GHS07
Dgr
H302
H315
H318
H317
   
607-511-00-3reaction mass of: 4-[(3-decyloxypropyl)(3-isobu-
toxy-1-isobutoxycarbonyl-3-
oxopropyl)amino]-4-oxobutyric acid;
4-[(3-isobutoxy-1-isobutoxy-
carbonyl-3-oxopropyl)(3-octy-
loxypropyl)amino]-4-oxo-
butyric acid
423-750-4Eye Irrit. 2
Aquatic Chronic 2
H319
H411
GHS07
GHS09
Wng
H319
H411
   
607-512-00-9trisodium 2,4-diamino-3,5-
bis-[4-(2-sulfonatoethoxy)sul-
fonyl)phenylazo]benzene-
sulfonate
423-970-0182926-43-8Aquatic Chronic 3H412H412